In-vitro bioassays for cholecystokinin

Area of Science:

• Pharmacology
• Biochemistry
• Assay Development

Background:

• Cholecystokinin (CCK) plays a crucial role in regulating digestive functions.
• Accurate bioassays are essential for quantifying CCK potency in pharmaceutical preparations.
• Existing bioassays may lack specificity or precision for certain applications.

Purpose of the Study:

• To develop and validate novel in-vitro bioassays for cholecystokinin (CCK).
• To assess the utility of these assays for determining the potency of CCK pharmaceutical formulations.
• To compare the precision and specificity of different in-vitro CCK bioassay methods.

Main Methods:

• Development of two in-vitro bioassays measuring CCK's stimulatory effect on guinea-pig pancreatic acinar cells.
• Assay 1: Measurement of 45Ca efflux from suspended acinar cells.
• Assay 2: Measurement of amylase release from pancreatic acini.

Main Results:

• Both in-vitro methods successfully recorded CCK's stimulatory effects.
• The 45Ca efflux assay demonstrated higher specificity and precision compared to the amylase release assay.
• Validation against the conventional guinea-pig gall-bladder contraction assay showed comparable potency readings with improved precision for the calcium assay.

Conclusions:

• The developed in-vitro bioassays, particularly the 45Ca efflux method, are suitable for quantifying CCK potency.
• The calcium efflux assay offers a more precise and specific alternative to traditional bioassays for pharmaceutical formulations.
• These assays provide valuable tools for the quality control and development of CCK-based therapeutics.